Filter
1997
Filtered Results: 1997
Text search:
registration
of
drugs
Featured
Recommendations
162
New Publications
656
Language
Document type
No document type
1304
Studies & Reports
257
Guidelines
216
Manuals
90
Strategic & Response Plan
77
Training Material
21
Fact sheets
16
Situation Updates
11
Resource Platforms
4
Brochures
1
Countries / Regions
India
194
Kenya
78
Uganda
54
Sierra Leone
51
Global
50
Ethiopia
48
Nigeria
47
South Africa
47
Nepal
45
Ghana
42
Tanzania
42
Bangladesh
41
Malawi
40
Rwanda
38
Western and Central Europe
35
Liberia
35
Myanmar / Burma
33
Africa
29
Namibia
29
Ukraine
28
Zambia
26
Latin America and the Carribbean
21
Philippines
19
Eastern Europe
19
Botswana
19
Cambodia
18
Syria
17
Zimbabwe
17
Lesotho
15
Asia
14
South–East Asia Region
14
Indonesia
14
South Sudan
13
Mozambique
12
Congo, Democratic Republic of
11
Eswatini/ Swaziland
8
Colombia
7
Tajikistan
6
Senegal
6
West and Central Africa
6
Russia
6
Sudan
6
Pakistan
6
East and Southern Africa
5
Moldova
5
Benin
4
Albania
4
Haiti
4
Venezuela
4
Jordan
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Lebanon
4
Brazil
4
North Macedonia
3
Chile
3
Cameroon
3
Iran
3
Afghanistan
3
Germany
3
Paraguay
3
United Kingdom
3
Argentina
3
Sri Lanka
3
Georgia
3
Libya
3
Iraq
3
Timor Leste/ East Timor
2
Thailand
2
China
2
Laos
2
Burkina Faso
2
Armenia
2
Saudi Arabia
2
Western Pacific Region
2
Uruguay
2
Turkmenistan
2
Bolivia
2
Papua New Guinea
2
Romania
2
Greece
2
Palestine
2
Central African Republic
2
Poland
2
Angola
2
Bhutan
2
Australia
1
Gambia
1
Kazakhstan
1
Fiji
1
Singapore
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Malaysia
1
Morocco
1
Qatar
1
Bulgaria
1
Guinea
1
Italy
1
USA
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
North America
1
Denmark
1
Maldives
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Djibouti
1
Egypt
1
Yemen
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1025
Clinical Guidelines
144
Public Health
95
Women & Child Health
74
Key Resources
66
Pharmacy & Technologies
35
Capacity Building
23
Toolboxes
TB
190
HIV
177
Mental Health
90
Pharmacy
78
AMR
78
COVID-19
73
NTDs
56
Conflict
53
Caregiver
39
Refugee
35
NCDs
34
Disability
31
Rapid Response
21
Global Health Education
17
Ebola & Marburg
15
Natural Hazards
13
Planetary Health
10
Health Financing Toolbox
10
Specific Hazards
8
Polio
5
Social Ethics
4
Cholera
3
Zika
3
South Sudan
2
Malaria
1
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market. The next steps taken to include these new innovati...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
The audit was undertaken in order to ascertain whether allocations and donations received directly by the Government of Sierra Leone, in the fight against the Ebola Virus Disease were utilised with due regard to economy and efficiency and that internal controls were observed accordingly. The audit f...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
2nd edition.
Like the original, this second edition of the guidance aims to inform the revision of existing national guidelines and standards for managing Tuberculosis (TB), many of which include guidance on children. It includes recommendations, based on the best available evidence, for improving ...
MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
Snakebites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snakebite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mortal...
Bull World Health Organ 2015;93:457–467 | doi: http://dx.doi.org/10.2471/BLT.14.147215
This publication by UNAIDS, UNDP and the International Organisation for Migration examines various dimensions related to migration and HIV and AIDS.
